NCT02345252 · Interventional trial
Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)
Overall registry status Completed
Phase 3
Conditions HIV-1 Infection
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory